Novartis profit tops expectations
Swiss drugmaker Novartis beat second-quarter sales and profit expectations, while keeping its 2021 guidance unchanged, as disruption from the coronavirus pandemic waned.
Suscribirse a:
Enviar comentarios (Atom)
Comentarios
Publicar un comentario
Leave a comment. Thanks!
Comentarios de Facebook